This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1987 Apr;110(4):636-9.

doi: 10.1016/s0022-3476(87)80569-3.

Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant

A Bairam, M J Boutroy, Y Badonnel, P Vert

PMID: 3559816
DOI: 10.1016/s0022-3476(87)80569-3

Clinical Trial

Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant

A Bairam et al. J Pediatr. 1987 Apr.

. 1987 Apr;110(4):636-9.

doi: 10.1016/s0022-3476(87)80569-3.

Authors

A Bairam, M J Boutroy, Y Badonnel, P Vert

PMID: 3559816
DOI: 10.1016/s0022-3476(87)80569-3

No abstract available

PubMed Disclaimer

Similar articles

Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants.
Brouard C, Moriette G, Murat I, Flouvat B, Pajot N, Walti H, de Gamarra E, Relier JP. Brouard C, et al. Am J Dis Child. 1985 Jul;139(7):698-700. doi: 10.1001/archpedi.1985.02140090060028. Am J Dis Child. 1985. PMID: 4014092 Clinical Trial.
[The choice between theophylline and caffeine in the treatment of apnea in premature infants].
Bairam A, Boutroy MJ, Badonnel Y, Vert P. Bairam A, et al. Arch Fr Pediatr. 1990 Jun-Jul;47(6):461-5. Arch Fr Pediatr. 1990. PMID: 2206108 Clinical Trial. French.
Methylxanthines in apnea of prematurity.
Aranda JV, Turmen T. Aranda JV, et al. Clin Perinatol. 1979 Mar;6(1):87-108. Clin Perinatol. 1979. PMID: 383366 Review.
The effect of caffeine compared with theophylline in the treatment of idiopathic apnea in premature infants.
Fuglsang G, Nielsen K, Kjaer Nielsen L, Sennels F, Jakobsen P, Thelle T. Fuglsang G, et al. Acta Paediatr Scand. 1989 Sep;78(5):786-8. doi: 10.1111/j.1651-2227.1989.tb11147.x. Acta Paediatr Scand. 1989. PMID: 2688355 Clinical Trial. No abstract available.
Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia.
McNamara DG, Nixon GM, Anderson BJ. McNamara DG, et al. Paediatr Anaesth. 2004 Jul;14(7):541-50. doi: 10.1111/j.1460-9592.2004.01351.x. Paediatr Anaesth. 2004. PMID: 15200650 Review. No abstract available.

See all similar articles

Cited by

Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis.
Miao Y, Zhou Y, Zhao S, Liu W, Wang A, Zhang Y, Li Y, Jiang H. Miao Y, et al. PLoS One. 2022 Sep 19;17(9):e0274882. doi: 10.1371/journal.pone.0274882. eCollection 2022. PLoS One. 2022. PMID: 36121807 Free PMC article.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
De Silva DTN, Petrovski M, Strunk T, Mukadam N, Page-Sharp M, Moore BR, Batty KT. De Silva DTN, et al. Eur J Clin Pharmacol. 2024 Jul;80(7):1079-1087. doi: 10.1007/s00228-024-03678-6. Epub 2024 Mar 28. Eur J Clin Pharmacol. 2024. PMID: 38546840 Free PMC article.
Caffeine therapy in preterm infants.
Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Abdel-Hady H, et al. World J Clin Pediatr. 2015 Nov 8;4(4):81-93. doi: 10.5409/wjcp.v4.i4.81. eCollection 2015 Nov 8. World J Clin Pediatr. 2015. PMID: 26566480 Free PMC article. Review.
Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.
Long JY, Guo HL, He X, Hu YH, Xia Y, Cheng R, Ding XS, Chen F, Xu J. Long JY, et al. Front Pharmacol. 2021 Jul 26;12:681842. doi: 10.3389/fphar.2021.681842. eCollection 2021. Front Pharmacol. 2021. PMID: 34381359 Free PMC article. Review.
Risks and benefits of therapies for apnoea in premature infants.
Hascoet JM, Hamon I, Boutroy MJ. Hascoet JM, et al. Drug Saf. 2000 Nov;23(5):363-79. doi: 10.2165/00002018-200023050-00002. Drug Saf. 2000. PMID: 11085344 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information